Why the study?
Are calcium channel blockers, angiotensin-converting enzyme inhibitors, and angiotensin II receptor antagonists safe in children with hypertension?
Are calcium channel blockers, angiotensin-converting enzyme inhibitors, and angiotensin II receptor antagonists safe in children with hypertension?
Answers are grounded in this paper and cite their sources.
Newer antihypertensive agents appear well-tolerated in children, though further studies are needed for chronic dosing and complex cases.
Hypertension is relatively uncommon in children and few children receive antihypertensive medications. This article reviews the safety of calcium channel blockers, angiotensin-converting enzyme inhibitors and angiotensin II receptor antagonists in children with hypertension. While the newer antihypertensive agents appear to be well-tolerated by children, further studies are needed to determine the safety profile across the developmental continuum, with chronic dosing and in children with complex hypertension.
No takes yet. Share an insight, caveat, or question.
Douglas L. Blowey (2002) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: